Compare Amazon.com Inc (AMZN) vs Novartis AG (NVS) Price & Performance

Amazon (AMZN) trades at $267.07, down 1.91% on the day, amid strong fundamental performance with revenue reaching $716.92 billion in 2025 and net income of $77.67 billion. The stock shows a bullish technical signal with moving averages supporting upward momentum, while oscillators remain neutral. Recent earnings beats in Q1 and Q2 2026 highlight operational strength, though Q4 2025 slightly missed expectations. Analyst consensus remains overwhelmingly positive with 89% buy ratings and a $333.86 price target.

Amazon's outlook is supported by robust revenue growth, expanding profit margins, and significant cash flow generation. Key risks include intense competition in e-commerce and cloud services, along with high capital expenditures. The stock presents a compelling opportunity for growth investors given its market leadership and AI-driven AWS expansion, though volatility from macroeconomic factors warrants caution.

Novartis (NVS) trades at $152.41, down 2.79% today, with technical indicators showing neutral momentum near key support at $152. The company reported strong Q2 2026 earnings that beat expectations, driven by oncology drug performance, while maintaining a robust 22.5% net margin and $56.7B in revenue. Recent institutional buying activity and a predominantly Hold analyst consensus reflect cautious optimism amid patent expiration headwinds.

The outlook balances strong fundamentals and pipeline progress against generic competition risks. Investment appeal lies in dividend stability and new drug growth, though Entresto sales decline and U.S. pricing pressures require monitoring. The stock presents a defensive opportunity with moderate upside potential if newer therapies continue outperforming.